Company / Current Liabilities per Share
Abbott Laboratories Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$9.43
FY2025
5-year range
$7.36 / $9.43
FY2021-FY2025
Trend
+17.5%
vs FY2024
Sector context
#53 of 158
Health Care
What the data says
At $9.43, Abbott Laboratories's current liabilities per share ranks #106 of 158 in the Health Care sector. Increased from $7.74 to $9.43 over the past 2 years.
Based on SEC 10-K filings.
9.43 in FY2025 with a 5-year CAGR of +7.0%.
Increased from $7.74 to $9.43 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +2.8%
- 5-Year CAGR
- +7.0%
- 10-Year CAGR
- -
Sector benchmark
#106 of 158 in Health CareTop 66% of 158This company $9.43 Sector average $29.75
▼
-68.3% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 17.5% year-over-year.
- Ranks #53 out of 158 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 31.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 27.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.43 | +17.5% |
| FY2024 | $8.03 | +3.7% |
| FY2023 | $7.74 | -10.8% |
| FY2022 | $8.67 | +17.9% |
| FY2021 | $7.36 | +9.4% |
| FY2020 | $6.73 | +8.3% |
| FY2019 | $6.21 | +2.2% |
| FY2018 | $6.08 | +2.7% |
| FY2017 | $5.92 | +35.7% |
| FY2016 | $4.36 | -25.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026